Polymorphic forms of Lapatinib ditosylate and processes for their preparation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8993579
APP PUB NO 20130123497A1
SERIAL NO

13642712

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is provided a crystalline form of Lapatinib, termed APO-I, and methods for making APO-I. There is also provided a crystalline solvate form of Lapatinib, termed APO-II, and methods for making APO-II.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
APOTEX PHARMACHEM INC34 SPALDING DRIVE BRANTFORD N3T6B8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cammisa, Eduardo Gustavo Oshawa, CA 7 1
Weeratunga, Gamini Ancaster, CA 45 114
Zetina-Rocha, Carlos Brantford, CA 7 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00